Nuclear factor erythroid 2 like 2 (Nrf2) functions as a neuroprotective agent in Parkinson's disease (PD). This study aimed to investigate the key long non-coding RNAs (lncRNAs) correlated with Nrf2, which might provide valuable information for the exploration of pathogenesis of PD. The lncRNA and mRNA expression profiling of substantia nigra and corpus striatum of Nrf2 (À/À) mice model was obtained from microarray analysis. The animal experiments conducted for this study were approved by the ethics committee of Hebei Medical University. Bioinformatics analyses were conducted, including differentially expressed lncRNAs/mRNA (differentially expressed lncRNA, DEL/differentially expressed mRNA, DEM) identification, DEL-DEM coexpression network construction, and biological functions prediction. Quantitative real-time polymerase chain reaction (qRT-PCR) was subjected to validate abnormally expressed DELs and DEMs in the substantia nigra and corpus striatum of Nrf2 (À/À) mice model. A total of 48 DELs (37 downregulated and 11 up-regulated) were identified both in Nrf2 (À/À) substantia nigra and corpus striatum; 96 DEMs and 643 DEMs were identified in the substantia nigra and corpus striatum, respectively. DEL-DEM coexpressed network was constructed. LncRNA AK076880, AK036620, and AK020330 had high connectivity with DEMs both in the substantia nigra and corpus striatum. These DEMs were significantly enriched in signaling pathways such as the calcium signaling pathway, Huntington's disease, Alzheimer's disease, mitogen-activated protein kinase (MAPK) signaling pathway, and the Wnt signaling pathway. Generally, qRT-PCR validation results of selected DEMs and DELs were consistent with microarray data. The dysregulated DELs and DEMs in the substantia nigra and corpus striatum of Nrf2 (À/À) mice were identified. Our results might provide useful information for further exploring the pathogenesis mechanism of PD.
Parkinson's disease (PD) is a chronic, progressive, degenerative neurologic disease, which is the second most common neurodegenerative disease, after Alzheimer disease (Wirdefeldt et al. 2011; Lawson et al. 2014) . Its pathologic features include loss of midbrain dopaminergic neurons in the substantia nigra and Lewy bodies largely composed of the protein a-synuclein (Balestrino and Martinez-Martin 2017) .
Despite fairly typical clinical and pathologic features, the etiology of PD remains unclear. Numerous mechanisms including oxidative stress, neuroinflammatory abnormality, and cell apoptosis have been reported as potential causes (Hirsch et al. 2013; Tolleson and Fang 2013; Deas et al. 2015) . However, oxidative stress is vital in PD pathology. Aggregation of a-synuclein forms soluble oligomers, which interact with metal ions to induce aberrant free radical production and neuronal toxicity, then results in oxidative stress and neuronal death in PD (Deas et al. 2015) .
Nrf2 (also named Nfe2la, full name is nuclear factor, erythroid 2 like 2) encodes a transcription factor, which is a member of a small family of basic leucine zipper proteins. Nrf2 regulates genes that encode antioxidant response elements in their promoters and is commonly involved in response to injury and inflammation, which includes the production of free radicals. Mounting evidence indicates that NRF2 is implicated in neuroprotection against the pathogenesis of PD. The NRF2 transcription factor signaling pathway is the most differentially expressed in olfactory neurospherederived cells (hONS) from patients with PD compared to control hONS cells, and hONS cells from the patient are in a state of oxidative stress because of higher production of H 2 O 2 than control cells (Cook et al. 2011) . It is reported that Nrf2-knockout mice exacerbate degeneration of nigral dopaminergic neurons and increase a-synuclein expression, which cooperate to aggravate neuronal death and inflammation in early-stage PD (Lastres-Becker et al. 2012) . In a Drosophila model of PD, over-expression of Nrf2 mediates a-synucleininduced dopaminergic neuron loss (Barone et al. 2011) .
A number of published articles demonstrate that dysregulated Nrf2/NRF2 contributes to aberrant expression of lncRNAs. LOC344887 is significantly up-regulated after ectopic expression of NRF2 in gallbladder cells and downregulation of LOC344887 promotes gallbladder cell tumorigenesis (Wu et al. 2017) . In lung cancer induced by cigarette smoke, the expression of lncRNA SCAL1 is regulated transcriptionally by NRF2 (Thai et al. 2013) . Nrf2 transcriptionally promotes the expression of lncRNA ODRUL in human chronic myeloid leukemia cell line K562 (Gao et al. 2017) . However, expression profiling of dysregulated lncRNAs associated with Nrf2 expression, which might be potentially involved in neuro-protection, has not been investigated. It is known that Nrf2 plays a neuroprotection role in PD pathology and pathogenesis mechanism of PD remains unclear.
In our study, expression profiling of the substantia nigra and corpus striatum tissue in Nrf2-knockout mice was obtained through microarray. Bioinformatics analyses including identification of dysregulated long non-coding RNAs and biological function enrichment were performed, aiming to investigate the key lncRNAs correlated with Nrf2 and provide valuable information for the exploration of pathogenesis mechanism of PD.
Materials and methods
Nrf2-knockout mice and ethics Adult male Nrf2 +/+ (25-30 g, n = 3) and Nrf2 À/À mice (25-30 g, n = 3) used in this study were kindly supplied by academician ChunYan Li (Department of Neurology, Second Hospital of Hebei Medical University, Shijiazhuang, China). Genotypes (Nrf2 +/+ and Nrf2 À/À ) of the mice were determined by polymerase chain reaction (PCR) amplification of genomic DNA from tails. All the mice were killed using an overdose of isoflurane/oxygen mixture. Both substantia nigra and corpus striatum tissues of each mouse were harvested by surgery and immediately homogenized for the extraction of total RNA (Trizol; Invitrogen, Carlsbad, CA, USA). The animal experiments complied with the regulations of the Animal Welfare Act of the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85-23, revised 1996) . The animal experiments conducted for this study were approved by the ethics committee of Hebei Medical University.
Microarray
Arraystar Mouse LncRNA Microarray V3.0 (Rockville, MA, USA) is designed for the global profiling of mouse lncRNAs and proteincoding transcripts, which is updated from the previous Microarray V2.0. Approximately, 35 923 lncRNAs and 24 881 coding transcripts can be detected by the third-generation lncRNA microarray. The LncRNAs are carefully constructed using the most reputed public transcription databases (Refseq, UCSC known genes, Ensembl, etc.), as well as landmark publications. Each transcript is represented by a specific exon or splice junction probe, which can identify the individual transcripts accurately. Positive probes for housekeeping genes and negative probes are also printed onto the array for hybridization quality control.
RNA labeling and array hybridization
Samples labeling and array hybridization were performed according to the Agilent One-Color Microarray-Based Gene Expression Analysis protocol (Agilent Technology, Palo Alto, CA, USA) with minor modifications. Briefly, mRNA was purified from total RNA after removal of rRNA (mRNA-ONLY Eukaryotic mRNA Isolation Kit; Epicentre, Madison, WI, USA). Then, each sample was amplified and transcribed into fluorescent cRNA along the entire length of the transcripts without 3 0 bias using the random priming method (Arraystar Flash RNA Labeling Kit; Arraystar, Rockville, MA, USA). The labeled cRNAs were purified by RNeasy Mini Kit (Qiagen, Valencia, CA, USA). The concentration and specific activity of the labeled cRNAs (pmol Cy3/lg cRNA) were measured by NanoDrop ND-1000 (NanoDrop Technologies, Thermo Scientific, Wilmington, DE, USA). One microgram of each labeled cRNA was fragmented by adding 5 lL 10 9 Blocking Agent and 1 lL of 25 9 fragmentation buffer, then the mixture was heated to 60°C for 30 min; finally, 25 lL 12 9 GE Hybridization buffer was added to dilute the labeled cRNA. Hybridization solution (50 lL) was assembled to the lncRNA expression microarray slide. According to the Agilent One-Color Microarray-Based Gene Expression Analysis protocol (Agilent Technologies, Inc., Santa Clara, CA, USA), the slides were incubated for 17 h at 65°C in an Agilent Hybridization Oven. Hybridized arrays were washed, fixed, and scanned using the Agilent DNA Microarray Scanner (part number G2505C).
Data pre-processing Agilent Feature Extraction software (version 11.0.1. 1) was used to analyze acquired array images. Quantile normalization and subsequent data processing were performed using the GeneSpring GX v12.1 software package (Agilent Technologies). After quantile normalization of the raw data, lncRNAs and mRNAs with at least 6 of 12 samples that have flags were chosen for further data analysis. Differentially expressed lncRNAs and mRNAs with statistical significance between the two groups were identified through p-value filtering. Differentially expressed lncRNAs and mRNAs between the two samples were identified through fold change filtering. Hierarchical clustering and combined analysis were performed using homemade scripts. As shown in Figure S1 (a) and (b), the relative expression signal of lncRNA and mRNA among 12 samples was compatible.
Differentially expressed lncRNAs and mRNAs analyses
The lncRNAs and mRNAs, with statistical significance between the two groups, were identified. The t-test was used to identify differently expressed lncRNAs (DELs) and differentially expressed mRNAs (DEMs). p-value and fold change (FC) were calculated for each DEM and DEL. The false discovery rate (FDR) was utilized for multiple testing corrections of raw p-value through the Benjamini and Hochberg method. Although FDR < 0.05 was a more rigorous benchmark of statistical difference, few DEMs and DELs were identified based on FDR < 0.05 and |log 2 FC|>1. Hence, DEMs and DELs were filtered based on raw p-values (p < 0.05) in our study, which was also a benchmark of statistical difference with a risk of type I error. Finally, lncRNAs and mRNAs with p < 0.05 and | log 2 FC|>1 were identified as DELs and DEMs. Hierarchical cluster analysis of group samples based on expression values of mRNA and lncRNAs was visualized through a 'pheatmap' package in R language.
Construction of lncRNA-mRNA coexpression network Pearson correlation coefficient (PCC) was used to depict the coexpression relationship between lncRNA and mRNA according to their expression levels. lncRNA-mRNA pairs with |PCC value ≥ 0.90| and p < 0.05 were retained for network construction, which was deciphered by Cytoscape 3.1 (http://cytoscape.org/).
Functional annotation
To gain insight into the biological functions of dysregulated genes, GeneCoDis 3 was assessed using gene ontology (GO) classification and the Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. FDR < 0.05 was set as the cutoff for selecting significantly enriched functional GO terms and a value of p < 0.05 was the threshold of the KEGG pathway.
Quantitative real-time polymerase chain reaction (qRT-PCR) Total RNA of the substantia nigra and corpus striatum tissues generated from the control group and the research group was extracted using Trizol (Thermo Fisher Scientific, Wilmington, DE, USA) according to the manual instructions. Total RNA (2 mg) was transcribed to cDNA using M-MLV First Strand Kit (Thermo Fisher Scientific Inc.). Quantitative real-time polymerase chain reaction (qRT-PCR) was performed using FastStart Universal SYBR Green Master (ROX) (Roche, Mannheim, Germany) with the QuantStudio3 instrument (Thermo Fisher Scientific). qRT-PCR reaction conditions were as follows: an initial denaturation step of 10 min at 95°C, followed by 40 cycles of 15 s at 95°C and 30 s at 60°C, 30 s at 72°C. b-Actin was selected as the housekeeping gene for normalization. All experiments were performed in triplicates. For quantitative results, the 2 ÀDDCT method was used to calculate relative fold changes. The PCR primers are shown in Table S4 .
Statistical analysis
Mean AE standard deviation and independent-samples t-test were used in the statistical analysis. A value of p < 0.05 was considered significant.
Results
DEMs and DELs in the substantia nigra between the Nrf2 (À/À) mice group and control group A total of 96 DEMs and 234 DELs were identified in Nrf2 (À/À) substantia nigra compared with control substantia nigra with the threshold of p < 0.05 and |log 2 FC>1|, respectively. The scatter diagram and volcano diagram of lncRNA and mRNA expression in substantia nigra are shown in Figure S1 (c-f). A total of 55 DEMs (57.30% of all DEMs) were down-regulated and 41 DEMs (42.70% of all DEMs) were up-regulated in Nrf2 (À/À) substantia nigra, Pou5f1 (49.2-fold down-regulation), and Gm11938 (8.5-fold upregulation) were the most significantly down-regulated and up-regulated DEMs (Table S1 ). A total of 160 DELs (68.38% of all DELs) were down-regulated and 74 DELs (31.62% of all DELs) were up-regulated. Nrf2 (À/À) substantia nigra, L3mbtl4 (27.8-fold down-regulation), and AK020441 (10.8-fold up-regulation) were the most significantly down-regulated and up-regulated DEMs (Table 1) . Hierarchical clustering of the expression of the 97 DEMs and 234 DELs indicated that there was obvious discrimination between Nrf2 (À/À) substantia nigra and control substantia nigra (Figures S2a and S3a) .
InNrf2 (À/À) substantia nigra, the biotype of identified 234 DELs, was divided into six categories. Twenty (8.55%) were bidirectional, 60 (25.64%) were exon sense-overlapping, 106 (45.30%) were intergenic, 6 (2.56%) were intronic antisense, 12 (5.13%) were intron sense-overlapping, and 30 (12.82%) were natural antisense (Fig. 1a ).
DEMs and DELs in corpus striatum between Nrf2 (À/À) mice group and control group A total of 643 DEMs and 716 differentially expressed lncRNAs (DELs) were identified in Nrf2 (À/À) corpus striatum compared with control corpus striatum with the threshold of p < 0.05 and |log 2 FC>1|, respectively. The scatter diagram and volcano diagram of lncRNA and mRNA expression in corpus striatum were shown in Figure S1 (g-j). A total of 157 DEMs (24.42% of all DEMs) were downregulated and 486 DEMs (75.58% of all DEMs) were upregulated in Nrf2 (À/À) corpus striatum, Gm14446 (8.99-fold down-regulation), and Pmch (205.7-fold up-regulation) were the most significantly down-regulated and upregulated DEMs (Table S2 ). There were 395 DELs (55.17% of all DELs) that were down-regulated and 321 DELs (44.83% of all DELs) were up-regulated in Nrf2 (À/À) corpus striatum, AA388235 (110.67-fold downregulation), and AK033955 (197.1-fold up-regulation) were the most significantly down-regulated and up-regulated DELs ( Table 2) .
The expression pattern of the 634 DEMs and 716 DELs in Nrf2 (À/À) corpus striatum compared with control corpus striatum showed obvious discrimination (Figures S2b and S3b) .
In Nrf2 (À/À) corpus striatum, the biotype of identified 716 DELs was divided into six categories. Twenty-nine (4.05%) were bidirectional, 213 (29.75%) were exon senseoverlapping, 296 (41.34%) were intergenic, 19 (2.65%) were DELs, differentially expressed long non-coding RNAs; FDR, false discovery rate; Nrf2, substantia nigra (Fig 1a) and corpus striatum (Fig 1b) of nuclear factor, erythroid-derived 2, like 2. Fig. 1 Pie chart of the biotype of identified differentially expressed lncRNAs in substantia nigra (Fig 1a) and corpus striatum (Fig 1b) of nuclear factor, erythroid-derived 2, like 2 (À/À) mice model.
intronic antisense, 76 (10.61%) were intron sense-overlapping, and 83 (11.59%) were natural antisense (Fig. 1b) .
Global gene expression changes in Nrf2 (À/À) mice To identify genes that had the global expression changes in the substantia nigra and corpus striatum, the identified DEMs/DELs in Nrf2 (À/À) substantia nigra were overlapped with those in Nrf2 (À/À) corpus striatum, respectively. A total of 48 DELs including 37 down-regulated and 11 upregulated genes were dysregulated both in the substantia nigra and corpus striatum tissues of Nrf2 (À/À) mice (Table S3 ). In addition, a total of 13 DEMs including nine down-regulated and four up-regulated DEMs were dysregulated both in the substantia nigra and corpus striatum tissues of Nrf2 (À/À) mice.
DEL-DEM coexpression network
To investigate the potential functions of DELs, the PCC indicating the coexpression relationship between DELs and DEMs was calculated. The DEMs in Nrf2 (À/À) substantia nigra and corpus striatum tissues, coexpressed with 48 DELs previously mentioned, were identified and the DEL-DEM coexpression network in Nrf2 (À/À) substantia nigra and corpus striatum were, respectively, constructed based on the expression profiling. As shown in Fig. 2 As shown in Figures S4-S6 , AK076880, AK036620, and AK020330 coexpressed with 365, 447, and 269 DEMs in Nrf2 (À/À) corpus striatum. ADP ribosylation factor like GTPase 8B (Arl8b) (PCC = À0.967 and p = 0.002) and malignant fibrous histiocytoma-amplified sequence 1 (Mfhas1) (PCC = À0.983 and p = 0.001) were negatively expressed with AK036620, whereas cyclic nucleotidebinding domain containing 2 (Cnbd2) (PCC = 0.967 and p = 0.002) and DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B (Ddx39b) (PCC = 0.985 and P = 0.001) were positively expressed with AK036620.
Functional annotation of DEMs
To obtain insight into the biological roles of DEMs in Nrf2 (À/À) mice, 96 DEMs in Nrf2 (À/À) substantia nigra combined with 643 DEMs Nrf2 (À/À) corpus striatum were assessed by GO and KEGG enrichment analyses. These DEMs were obviously responsive to synaptic transmission, oxidation-reduction process, positive regulation of neuron projection development, and nervous system development of biological processes; the DEMs were significantly enriched in post-synaptic density, axon, post-synaptic membrane, and neuronal cell body of cellular components; in addition, the DEGs (differentially expressed genes) were significantly enriched in voltage-gated potassium channel activity and ATP-binding and transferase activity of molecular function (Fig. 3a-c , Table S5 ). Moreover, DEMs were significantly enriched in a series of KEGG pathways including Alzheimer's disease (KEGG: 05010), Huntington's disease (KEGG: 05016), mitogen-activated protein kinase (MAPK) signaling pathway (KEGG: 04010), and Wnt signaling pathway (KEGG: 04310) (Fig. 3d , Table S6 ).
QRT-PCR validation of the expression levels of candidate DELs
To validate the expression level of DELs and DEMs identified through our bioinformatics analyses, qRT-PCR was used for detecting the expression level of DELs in the substantia nigra and corpus striatum tissues of three Nrf2 (À/À) mice models and three control mice. A total of seven DELs (Vmn2r29, AK134720, AK020330, AK036620, AK082534, 5330439K02Rik, and Gm422) in Nrf2 (À/À) substantia nigra or Nrf2 (À/À) corpus striatum were representative DELs for qRT-PCR verification. Among these seven DELs, AK036620 was significantly down-regulated both in substantia nigra and corpus striatum and Vmn2r29 was significantly up-regulated in both substantia nigra and corpus striatum (Table 1) ; AK134720 was significantly down-regulated in corpus striatum while significantly upregulated in the substantia nigra based on our microarray analysis. AK020330 and AK082534 were randomly selected from all the DELs in the substantia nigra; 5330439K02Rik and Gm4221 were randomly selected from all the DELs in the corpus striatum based on the microarray results. As shown in Fig. 4 (a), AK082534 and AK036620 were downregulated, whereas Vmn2r29, AK134720, and AK020330
were up-regulated in substantia nigra tissues of Nrf2 (À/À) mice; AK134720, AK036620, and 5330439K02Rik were down-regulated, whereas Gm4221 and Vmn2r29 were upregulated in Nrf2 (À/À) corpus striatum. The expression levels of these seven DELs in our qRT-PCR results were consistent with our microarray results.
qRT-PCR validation of the expression levels of candidate DEMs
Based on the microarray results, three down-regulated DEMs (Gm14446, Krt12, and Tmem132d) and up-regulated Vmn2r51 in the substantia nigra of Nrf2 (À/À) mice model and two up-regulated DEMs (Mfhas1 and Arl8b) and two down-regulated DEMs (Cnbd2 and Ddx39b) in the corpus striatum of Nrf2 (À/À) mice model were representative DEMs for qRT-PCR verification. In addition, these eight DEMs were all coexpressed with AK036620. According to Fig. 4(b) , Gm14446 and Krt12 were down-regulated while Vmn2r51 and Tmem132d were up-regulated in the substantia nigra tissues of Nrf2 (À/À) mice; Mfhas1 and Arl8b were up-regulated while Cnbd2 and Ddx39b were down-regulated in the corpus striatum tissues of Nrf2 (À/À) mice based on our qRT-PCR results. Except for Tmem132d, the expression levels of the seven DEMs were consistent with our microarray results.
Discussion
It is known that Nrf2 functions in a neuroprotection role in PD pathology. To reveal the genes and signaling pathways correlated with Nrf2 in PD, dysregulated lncRNA and mRNA in the substantia nigra and corpus striatum tissues of Nrf2 (À/À) mice models were identified through microarray and systematical bioinformatics analysis. Mucin-like 1 (Mucl1) (also named Spt2), transcription factor CP2 (Tfcp2), Ubc, Fas, and Tweety family member 1 (Ttyh1) were dysregulated in Nrf2 (À/À) mice models. Mucl1, Tfcp2, and Fas were down-regulated; moreover, Ubc and Ttyh1 were up-regulated both in the substantia nigra and corpus striatum tissues of Nrf2 (À/À) mice models. In the lncRNA-mRNA coexpression network of substantia nigra, those five DEMs had high connectivity with DEMs, which coexpressed with 136, 132, 128, 126, and 120 DELs, respectively.
Mucl1 was a common DEM derived from the top 10 down-regulated DEMs both in Nrf2 (À/À) substantia nigra and corpus striatum. A previous study demonstrated that hypoxia increases the activity and protein levels of SPT2, and specific siRNA of SPT2 prevents hypoxia-induced neuronal apoptosis by synthesis of ceramide . Tfcp2 encodes transcription factor CP2, which contributes to the pathogenesis of Alzheimer's disease (AD). b-Amyloid protein accumulation, the key pathological feature of AD, induces neurotoxicity in the cortex and hippocampus through up-regulating the mRNA and protein levels of Tfcp2, which induces transferrin expression (Jang et al. 2010) . A meta-analysis indicates that an allele of the 3 0 untranslated region of single nucleotide polymorphism of TFCP2 is associated with an increased risk for AD (Bertram et al. 2005) . In addition, TFCP2 is aberrantly expressed in hepatocellular carcinoma (HCC) and skin melanoma. Overexpressed TFCP2 functions as an oncogenic role in HCC pathogenesis. Inhibition of TFCP2 abrogates HCC cell growth and metastasis in vivo and in vitro (Santhekadur et al. 2012; Rajasekaran et al. 2015 ). However, the expression level of TFCP2 is decreased in melanoma, and up-regulated TFCP2 suppresses melanoma cell growth and increases the percentage of G1 phase cells (Goto et al. 2016) .
Ubc and Ttyh1 were significantly up-regulated in both the substantia nigra and corpus striatum tissues of Nrf2 (À/À) mice models. Ubc encodes ubiquitin C. A number of reports indicate that dysregulated ubiquitin is implicated in neurodegenerative disease. Ubc is up-regulated in the cerebrospinal fluid of patients with PD and not in matched healthy controls, and might be a potential PD biomarker (Hossein-Nezhad et al. 2016) . In Huntington disease (HD), neurological phenotype improvements in various behavioral activities were observed in Ubc knockout HD mice through rotarod, grip strength, and weight loss analyses (Bett et al. 2009 ). Ttyh1 encodes Tweety family member 1, which is a member of the Tweety family of membrane proteins and displays calcium-binding activity. It is reported that the mammalian Ttyh1 gene is restricted mainly to the neural tissue and is up-regulated in astrocytoma, glioma, and several other cancers. In whole rat brain slices, Ttyh1 is expressed around the hippocampus. Ttyh1 might play a role in process formation, cell adhesion, and possibly as a transmembrane receptor (Matthews et al. 2007) .
Fas encodes the tumor necrosis factor receptor superfamily member 6. Fas was a DEM derived from the top 10 upregulated DEMs both in Nrf2 (À/À) substantia nigra and corpus striatum. Fas, which is one of the death receptors, mediates apoptotic cell death in response to external stimuli. In mice, lacking Faim 2 (Fas-associated inhibitory molecule 2) increases cell death in the MPTP mouse model of PD (Komnig et al. 2016) . In mononuclear cells from patients with PD, ubiquitin-proteasome system dysfunction and upregulation of a-synuclein gene is related to high expression of the Fas protein, activation of caspase-3 and -9, and increased likelihood for apoptosis (Macchi et al. 2015) . In the KEGG signaling pathway enrichment analysis, Fas was significantly enriched in AD and MAPK signaling pathway (Table S6 ).
In the DEL-DEM coexpression networks, lncRNA AK076880, AK036620, and AK020330 had high connectivity with DEMs in both Nrf2 (À/À) substantia nigra and corpus striatum. AK076880 was down-regulated by 14.1-fold in the substantia nigra and was down-regulated by 58.0-fold in the corpus striatum, respectively. In Nrf2 (À/À) substantia nigra, AK076880 coexpressed with 62 DEMs including Mucl1, Tfcp2, Ubc, Fas, and Ttyh1; it coexpressed with 365 DEMs including Ubc, Fas, and Ttyh1 in Nrf2 (À/À) corpus striatum. AK076880 was one of the DELs derived from the top 10 up-regulated DELs both in Nrf2 (À/À) substantia nigra and corpus striatum. In the network, amyloid beta (A4) precursor protein-binding, family B, member 1, Atp5d, Fas, Ncstn, Eif2ak3, nitric oxide synthase 1 (Nos1), and glutamate receptor, ionotropic, NMDA1 (zeta 1) (Grin1) coexpressed with AK076880, which were enriched in AD. It is reported that both Nos1 and Grin1 are implicated in PD pathogenesis. The higher expression level of NOS1 in patients with PD caused by promoter polymorphism upon transcription is associated with PD. Hyperactivation of N-methyl-D-aspartate receptors leads to neuronal excitotoxicity and is suggested to play a role in brain disorders, including AD and schizophrenia. GRIN1 and glutamate ionotropic receptor NMDA type subunit 2D (GRIN2D) are the subunits of NMDARs. A recent study demonstrates that GRIN1 and GRIN2D are the hub genes in the protein-protein network of PD based on gene expression profiling analysis (Liu et al. 2016) . Multiple polymorphisms of GRIN1 and GRIN2BC366G synergistically affect risk reduction in PD (Wu et al. 2010) . The roles of AK076880 correlated with PD pathogenesis remain unclear.
LncRNA AK036620 was also a DEL derived from the top 10 up-regulated DELs both in Nrf2 (À/À) substantia nigra and corpus striatum. In Nrf2 (À/À) substantia nigra, AK036620 coexpressed with 57 DEMs including PTK2 protein tyrosine kinase 2 beta, Cacna2d1, Fas, Gm14446, Krt12, and Tmem132d; it coexpressed with 447 DEMs including Grin1, Ncstn, MAP kinase-activated protein kinase 2 (Mapkapk2), Mfhas1, Arl8b, Cnbd2, and Ddx39b in Nrf2 (À/À) corpus striatum. A number of articles indicate that these genes are correlated with nervous disorders. PTK2 protein tyrosine kinase 2 beta, a calcium-dependent, nonreceptor protein tyrosine kinase of the focal adhesion kinase (FAK) family, is highly expressed in neurons and is present in astrocytes, and is essential for astrocyte motility following brain lesion in in vitro wound healing model (Giralt et al. 2016) . Cacna2d1 encodes a regulatory component of the voltage-dependent calcium channel complex, which is involved in neuron function. In the Cacna2d1(À/À) mice model with partial sciatic nerve ligation, Cacna2d1 loss delays mechanical hypersensitivity in response to peripheral nerve damage (Patel et al. 2013; Zhou and Luo 2014) . Ncstn encodes nicastrin and is a component of c-secretase, which produces b-amyloid in AD. Nsctn deficiency restricts bamyloid deposition and amyloid plaque formation in an AD mouse model (Sesele et al. 2013) . Moreover, the loss of nicastrin from oligodendrocytes contributes to hypomyelination and schizophrenia with compulsive behavior through altered dopamine signaling in a Nsctn (À/À) mice model (Dries et al. 2016) . Mapkapk2 encodes MAPK-activated protein kinase 2 and is involved in PD pathogenesis. Mapkapk2 deficiency prevents neurons from cell death by impeding neuroinflammation in Mapkapk2 (À/À) mice model of PD (Thomas et al. 2008) . Furthermore, in an AD mice model, its deficiency in microglia inhibits proinflammatory mediator release and b-amyloid accumulation (Culbert et al. 2006) . Up-regulated Tmem132d in the frontal cortex was reported to be associated with the risk genotypes for PD, which suggested that Tmem132d may be a candidate gene for PD (Erhardt et al. 2011) . The up-regulated Tmem132d was identified in Nrf2 (À/À) substantia nigra mice according to the qRT-PCR results. However, this result was inconsistent with our microarray analysis, which needs further study. A previous study has reported that Ddx39b was closely associated with the risk of late-onset AD in the Iranian population (Soosanabadi et al. 2015) . We speculated that lncRNA AK036620 may play an important role in the pathogenesis of PD by regulating these coexpressed DEMs.
LncRNA AK020330 was another DEL derived from the top 10 up-regulated DEL both in Nrf2 (À/À) substantia nigra and corpus striatum. In Nrf2 (À/À) substantia nigra, it coexpressed with 59 DEMs including Cacna2d1, Fas, Gm14446, Krt12, Tmem132d, and Vmn2r51; it coexpressed with 269 DEMs including Ppp2r1a, Eif2ak3, Grin1, and Mapkapk2 in Nrf2 (À/À) corpus striatum. Ppp2r1a (protein phosphatase 2, regulatory subunit A, alpha) is one of the four major Ser/Thr phosphatases. Aberrantly expressed PPP2R1A in astrocytes of the rat hypothalamus is involved in chronic sleep deprivation, which influences cognition and memory (Kim et al. 2014) . Eif2ak3 protein (also named Perk), located in the endoplasmic reticulum, is thought to modulate mitochondrial function. Mounting evidence indicates that Eif2ak3 plays roles in nervous disorders. PREK protein contributes to hippocampal synaptic plasticity because of increased eIF2a phosphorylation and is associated with hippocampal metabotropic glutamate receptor-dependent long-term depression (Trinh et al. 2014) . PERK activation is increased in neurodegenerative disorders including AD, tauopathies, and prion disorders (Radford et al. 2015) . Deletion of PERK alleviates AD-related plasticity and memory deficits in AD mice model (Ma et al. 2013) . The roles of AK076880 correlated with PD pathogenesis remain unclear.
A total of 48 DELs were identified both in Nrf2 (À/À) substantia nigra and corpus striatum tissues. Most of those DELs were first reported to be involved in Nrf2 neuroprotection in PD. These novel DELs coexpressed with DMEs, which were significantly enriched in the calcium signaling pathway, HD, AD, MAPK signaling pathway, and Wnt signaling pathway; this suggested that dysregulated lncRNA and mRNA might synergistically play essential roles through regulated pathways in PD. Whether these novel dysregulated DELs refer to the PD pathogenesis needs to be clarified through in vivo and in vitro experiments in future work. In addition, dysregulated signaling pathways of aberrantly expressed genes associated with Nrf2 knockout were identified, and the potential roles of these pathways in PD pathogenesis need further exploration.
In conclusion, we identified the expression profiling of abnormally expressed lncRNAs and protein-coding RNAs in the substantia nigra and corpus striatum of Nrf2 (À/À) mice. Our study might be the foundation for future investigation to shed light on the molecular mechanisms of PD pathogenesis.
Author contributions
The study was designed by Lei Wang, Ge-Ming Shi, and Hui-Xian Cui; the experiments were performed by Jian Liu and Shan-Hu Cao; the data were analyzed by Shao-Guang Sun; and the draft was written by Yun-Xiao Kang, Jian Liu, Ya-Li Xu and Lei Wang.
Acknowledgments and conflict of interest disclosure
We are grateful to academician Chun-Yan Li for supplying the experimental animal, and to Shu-Xia Liu for technical assistance and valuable advice on this project. This work was financially supported by Research Development Fund of Hebei Medical University (grant number kyfz022); National Natural Science Foundation of China (grant number 81670273, 81200215); and Excellent Youth Foundation of the Higher Education Institutions of Hebei Province (YQ2013023). The authors have no conflict of interest to declare.
All experiments were conducted in compliance with the ARRIVE guidelines.
Supporting information
Additional Supporting Information may be found online in the supporting information tab for this article: Figure S1 . Box-plot analysis, scatter diagram, and volcano diagram of relative expression signal of lncRNA and mRNA among 12 samples. Figure S2 . Hierarchical clustering analysis based on the expression profile of the dysregulated DELs in Nrf2 (À/À) substantia nigra (a) and corpus striatum (b) between Nrf2 (À/À) mice model and normal mice. Figure S3 . Hierarchical clustering analysis based on the expression profile of the dysregulated DEMs in Nrf2 (À/À) substantia nigra (A) and corpus striatum (B) between Nrf2 (À/À) mice model and normal mice. Figure S4 . Subnetwork of AK076880 in Nrf2 (À/À) corpus striatum. Figure S5 . Subnetwork of AK036622 in Nrf2 (À/À) corpus striatum. Figure S6 . Subnetwork of AK020330 in Nrf2 (À/À) corpus striatum. Table S1 . Top 10 up-and down-regulated DEMs in Nrf2(À/À) substantia nigra. Table S2 . Top 10 up-and down-regulated DEMs in Nrf2(À/À) corpus striatum. Table S3 . Global lncRNA expression changes in Nrf2(À/À) mice. Table S4 . The primers used in qRT-PCR experiments. Table S5 . The Gene Ontology terms enrichment analyses of DEMs in Nrf2 (À/À) mice model. Table S6 . The KEGG signaling pathway enrichment analyses of DEMs in Nrf2 (À/À) mice model.
